Primary prophylaxis of variceal hemorrhage in children with portal hypertension: A framework for future research

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 3, 2011, Pages 254-261

  Ling, Simon C ^a   Walters, Thomas ^a   McKiernan, Patrick J ^b   Schwarz, Kathleen B ^c   Garcia Tsao, Guadalupe ^d   Shneider, Benjamin L ^e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

endoscopic variceal ligation; esophageal varices; nonselective blockers; portal hypertension; primary prophylaxis; variceal bleeding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; PLACEBO; PROPRANOLOL;

BEHAVIOR DISORDER; CHILD CARE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES BLEEDING; HEMODYNAMICS; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LIVER CIRRHOSIS; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PEDIATRICS; PORTAL HYPERTENSION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CHILD; COMBINED MODALITY THERAPY; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIGATION;

EID: 79952310596     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318205993a     Document Type: Review

References (62)

1. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-38. (Pubitemid 47436138)
2. Shneider BL. Approaches to the management of pediatric portal hypertension: results of an informal survey. In: Groszmann RJ, Bosch J, eds. Portal Hypertension in the 21st Century. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2004:167-72.
3. Schreiber RA. Propranolol and portal hypertension: should kids be on the block? J Pediatr Gastroenterol Nutr 1999;29:10-1.
4. Molleston JP. Variceal bleeding in children. J Pediatr Gastroenterol Nutr 2003;37:538-45. (Pubitemid 39280857)
5. Shneider B, Emre S, Groszmann R, et al. Expert pediatric opinion on the report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 2006;10:893-907. (Pubitemid 44683633)
6. Superina R, Shneider B, Emre S, et al. Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant 2006;10:908-13. (Pubitemid 44683634)
7. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
8. Wanless IR, Wong F, Blendis LM, et al. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995;21:1238-47.
9. Garcia-Pagan JC, Bosch J, Rodes J. The role of vasoactive mediators in portal hypertension. Semin Gastrointest Dis 1995;6:140-7.
10. Ballet F, Chretien Y, Rey C, et al. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. J Pharmacol Exp Ther 1988;244:283-9. (Pubitemid 18042394)
11. Farzaneh-Far R, Moore K. Cysteinyl-leukotrienes and the liver. Prostaglandins Other Lipid Mediat 2003;72:35-50. (Pubitemid 39220484)
12. Kaneda K, Ekataksin W, Sogawa M, et al. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 1998;27:735-47. (Pubitemid 28103550)
13. Kawada N, Tran-Thi TA, Klein H, et al. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993;213:815-23. (Pubitemid 23125653)
14. Benoit JN, Zimmerman B, Premen AJ, et al. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986;251(5 Pt 1):G674-7.
15. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-91. (Pubitemid 34110432)
16. Bosch J, D'Amico G, Garcia-Pagan JC. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003:429-85.
17. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004;39:280-2. (Pubitemid 38222164)
18. Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-24. (Pubitemid 15065948)
19. Lebrec D. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther 1994;61:65-107. (Pubitemid 24210636)
20. Westaby D, Bihari DJ, Gimson AE, et al. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut 1984;25:121-4. (Pubitemid 14131402)
21. Lebrec D, Hillon P, Munoz C, et al. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982;2:523-7. (Pubitemid 13173931)
22. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505. (Pubitemid 30032646)
23. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-4. (Pubitemid 36332114)
24. Turnes J, Garcia-Pagan JC, Abraldes JG, et al. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006;101:506-12. (Pubitemid 43340926)
25. Garcia-Tsao G, Grace ND, Groszmann RJ, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986;6:101-6. (Pubitemid 16137851)
26. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001;33:802-7. (Pubitemid 32246627)
27. Bosch J, Garcia-Tsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is. . .. Hepatology 2009;50:674-7.
28. Tripathi D, Ferguson JW, Kochar N, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009;50:825-33.
29. Fernandez M, Vizzutti F, Garcia-Pagan JC, et al. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004;126:886-94. (Pubitemid 38298336)
30. Fernandez M, Mejias M, Garcia-Pras E, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 2007;46:1208-17. (Pubitemid 350144785)
31. Sokal EM, Van HN, Van OL, et al. Upper gastro-intestinal tract bleeding in cirrhotic children candidates for liver transplantation. Eur J Pediatr 1992;151:326-8.
32. Stringer MD, Howard ER, Mowat AP. Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia. J Pediatr Surg 1989;24:438-42. (Pubitemid 19121605)
33. Miga D, Sokol RJ, Mackenzie T, et al. Survival after first esophageal variceal hemorrhage in patients with biliary atresia. J Pediatr 2001;139:291-6. (Pubitemid 32721720)
34. Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148:467-74.
35. Hussey S, Kelleher K, Ling SC. Prospective study of major upper gastrointestinal hemorrhage in children [abstract]. Can J Gastroenterol 2008;22(Suppl A):156A.
36. Goncalves ME, Cardoso SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. J Pediatr Surg 2000;35:401-5. (Pubitemid 30131600)
37. Lykavieris P, Gauthier F, Hadchouel P, et al. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. J Pediatr 2000;136:805-8. (Pubitemid 30415657)
38. Eroglu Y, Emerick KM, Whitingon PF, et al. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004;38:41-7. (Pubitemid 39274466)
39. van Heurn LW, Saing H, Tam PK. Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. J Pediatr Surg 2004;39:6-9. (Pubitemid 38049827)
40. de FR. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008;49:520-7.
41. Fagundes ED, Ferreira AR, Roquete ML, et al. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome. J Pediatr Gastroenterol Nutr 2008;46:178-83. (Pubitemid 351161124)
42. Gana JC, Turner D, Roberts EA, et al. Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children. J Pediatr Gastroenterol Nutr 2010;50:188-93.
43. Chang HK, Park YJ, Koh H, et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009;49:323-8.
44. Ozsoylu S, Kocak N, Yuce A. Propranolol therapy for portal hypertension in children. J Pediatr 1985;106:317-21. (Pubitemid 15130091)
45. de Kolster CC, Rapa de HM, Carvajal A, et al. Propranolol in children and adolescents with portal hypertension: its dosage and the clinical, cardiovascular and biochemical effects. G E N 1992;46:199-207. (Pubitemid 24017506)
46. Shashidhar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study. J Pediatr Gastroenterol Nutr 1999;29:12-7. (Pubitemid 30345821)
47. Ozsoylu S, Kocak N, Demir H, et al. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turk J Pediatr 2000;42:31-3. (Pubitemid 30143322)
48. Sokucu S, Suoglu OD, Elkabes B, et al. Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children. Pediatr Int 2003;45:388-94. (Pubitemid 37129923)
49. Erkan T, Cullu F, Kutlu T, et al. Management of portal hypertension in children: a retrospective study with long-term follow-up. Acta Gastroenterol Belg 2003;66:213-7. (Pubitemid 37295880)
50. Arnon R, Srivastava S, Fahey M, et al. Hyperdynamic circulation in infants with biliary atresia and portal hypertension [abstract]. Hepatology 2007;46:720A.
51. Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999;34:1813-22.
52. Zargar SA, Javid G, Khan BA, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology 2002;36:666-72. (Pubitemid 34977177)
53. McKiernan PJ. Treatment of variceal bleeding. Gastrointest Endosc Clin N Am 2001;11:789-812. viii.
54. Code of Federal Regulations, Title 45 Public Welfare, Part 46 Protection of Human Subjects, US Department of Health and Human Services.
55. Merkel C, Zoli M, Siringo S, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000;95:2915-20.
56. Gana JC, Turner D, Avitzur Y, et al. Prediction of esophageal variceal bleeding in children [abstract]. Gastroenterology 2009;136(5 Suppl 1):A825.
57. Paquet KJ. Ten years experience with paravariceal injection sclerotherapy of esophageal varices in children. J Pediatr Surg 1985;20:109-12.
58. Howard ER, Stringer MD, Mowat AP. Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices. Br J Surg 1988;75:404-8.
59. Maksoud JG, Goncalves ME, Porta G, et al. The endoscopic and surgical management of portal hypertension in children: analysis of 123 cases. J Pediatr Surg 1991;26:178-81.
60. Cano I, Urruzuno P, Medina E, et al. Treatment of esophageal varices by endoscopic ligation in children. Eur J Pediatr Surg 1995;5:299-302.
61. Sasaki T, Hasegawa T, Nakajima K, et al. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia. J Pediatr Surg 1998;33:1628-32. (Pubitemid 28530413)
62. Celinska-Cedro D, Teisseyre M, Woynarowski M, et al. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg 2003;38:1008-11. (Pubitemid 36828864)